MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AdaptHealth Corp. Operating Expenses 2011-2026 | AHCO
Annual Operating Expenses AdaptHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 59.6 M | 1.23 M | 690 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 59.6 M | 690 | 20.3 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B |  USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.62 | -1.31 % | $ 38.6 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.22 | - | $ 121 M |  France |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.67 | -0.98 % | $ 330 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 95.25 | 0.39 % | $ 12.9 B | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 26.39 | -0.34 % | $ 223 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.28 | 5.56 % | $ 1.39 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.41 | 1.36 % | $ 385 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 5.33 | -0.09 % | $ 1.13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 63.87 | -0.51 % | $ 3.48 B |  Britain |
 |
LENSAR
LNSR
|
32.6 M | $ 5.08 | -0.2 % | $ 60.7 M | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.97 | 1.2 % | $ 393 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.09 | 2.83 % | $ 18.5 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 39.18 | 2.08 % | $ 1.22 B | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 55.85 | -0.75 % | $ 1.64 B | USA |
 |
Insulet Corporation
PODD
|
531 M | $ 191.14 | 0.83 % | $ 13.4 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 85.95 | -0.06 % | $ 2.99 B | USA |
 |
PAVmed
PAVM
|
54.3 M | $ 9.11 | 1.22 % | $ 6.11 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 83.94 | -0.37 % | $ 49.1 B | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.43 | -1.62 % | $ 6.74 M | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 3.46 | 0.87 % | $ 511 M | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 328.6 | 0.34 % | $ 126 B | USA |
 |
Tactile Systems Technology
TCMD
|
221 M | $ 25.34 | 1.08 % | $ 580 M | USA |
 |
Nevro Corp.
NVRO
|
396 M | - | - | $ 217 M | USA |